In Silico Modeling as a Perspective in Developing Potential Vaccine Candidates and Therapeutics for COVID-19
Open Access
Abstract
The potential of computational models to identify new therapeutics and repurpose existing drugs has gained significance in recent times. The current ‘COVID-19’ pandemic caused by the new SARS CoV2 virus has affected over 200 million people and caused over 4 million deaths. The enormity and the consequences of this viral infection have fueled the research community to identify drugs or vaccines through a relatively expeditious process. The availability of high-throughput datasets has cultivated new strategies for drug development and can provide the foundation towards effective therapy options. Molecular modeling methods using structure-based or computer-aided virtual screening can potentially be employed as research guides to identify novel antiviral agents. This review focuses on in-silico modeling of the potential therapeutic candidates against SARS CoVs, in addition to strategies for vaccine design. Here, we particularly focus on the recently published SARS CoV main protease (Mpro) active site, the RNA-dependent RNA polymerase (RdRp) of SARS CoV2, and the spike S-protein as potential targets for vaccine development. This review can offer future perspectives for further research and the development of COVID-19 therapies via the design of new drug candidates and multi-epitopic vaccines and through the repurposing of either approved drugs or drugs under clinical trial.Keywords
This publication has 117 references indexed in Scilit:
- Vaccine delivery using nanoparticlesFrontiers in Cellular and Infection Microbiology, 2013
- A review of vaccine development and research for industry animals in KoreaClinical and Experimental Vaccine Research, 2012
- A novel strategy of epitope design in Neisseria gonorrhoeaeBioinformation, 2010
- Rationalizing the development of live attenuated virus vaccinesNature Biotechnology, 2010
- Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL proteaseBioorganic & Medicinal Chemistry Letters, 2010
- Investigation of the pharmacophore space of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) NTPase/helicase by dihydroxychromone derivativesBioorganic & Medicinal Chemistry Letters, 2009
- Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitorsBioorganic & Medicinal Chemistry Letters, 2008
- Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- Structural analysis of inhibition mechanisms of Aurintricarboxylic Acid on SARS-CoV polymerase and other proteinsComputational Biology and Chemistry, 2005
- A DNA vaccine induces SARS coronavirus neutralization and protective immunity in miceNature, 2004